Showing results (3291-3300 of 3,354) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|July 15, 2004
Economic aspects of pneumococcal pneumonia: a review of the literatureDiana De Graeve, Philippe BeutelsPharmacoeconomics|May 13, 2004
Economic evaluations of treatments for systemic fungal infections: a systematic review of the literatureSimon Dixon, Emma McKeen, Margaret Tabberer, et al.Pharmacoeconomics|November 5, 2003
Escitalopram: a pharmacoeconomic review of its use in depressionKatherine F Croom, Greg L PloskerPharmacoeconomics|February 12, 2004
Cost-of-illness studies in diabetes mellitusLorraine Ettaro, Thomas J Songer, Ping Zhang, et al.Pharmacoeconomics|October 28, 2006
Information created to evade reality (ICER): things we should not look to for answersStephen Birch, Amiram GafniPharmacoeconomics|June 6, 1998
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatinM J Koren, D G Smith, D B Hunninghake, et al.Pharmacoeconomics|July 23, 2016
The Value of Medicines: A Crucial but Vague ConceptFernando Antoñanzas, Robert Terkola, Maarten PostmaPharmacoeconomics|January 13, 2016
Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel ApproachesDyfrig Hughes, Joanna Charles, Dalia Dawoud, et al.Pharmacoeconomics|October 19, 2015
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics CommunityBernhard Ultsch, Oliver Damm, Philippe Beutels, et al.Pageof 336